Found 52 matching trials
A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult Participants PHASE1 This study will assess the pharmacokinetics, relative bioavailability, immu...
Show More Location
Altasciences Clinical Los Angeles /ID# 276446
Learn More & Join Trial
A Study to Assess Pharmacokinetic Exposures Following Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants PHASE1 The objective of this study is to compare pharmacokinetic exposures followi...
Show More Location
Clinical Pharmacology Of Miami /ID# 268219
Learn More & Join Trial
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease PHASE2 Crohn's disease (CD) is a long-lasting disease that causes severe inflammat...
Show More Location
Digestive Health Specialists /ID# 266216
Learn More & Join Trial
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) PHASE3 The purpose of this study is to evaluate the safety and efficacy of risanki...
Show More Location
Pinnacle Research Group /ID# 167953
Learn More & Join Trial
Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis PHASE3 The main objective of this study is to evaluate the efficacy and safety of ...
Show More Location
Advanced Research Associates - Glendale /ID# 204335
Learn More & Join Trial
A Study to Evaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adult Participants PHASE1 The objective of this study is to evaluate the bioavailability of risankizu...
Show More Location
Acpru /Id# 210844
Learn More & Join Trial
Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation PHASE3 The purpose of this study is to assess the safety and efficacy of risankizu...
Show More Location
GBUZ Clinical Dermatovenerology Dispensary of MoH of Krasnodar region /ID# 201713
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers PHASE1 Safety, tolerability and pharmacokinetics of single dose of BI 655066/ABBV-...
Show More Location
Boehringer Ingelheim Investigational Site
Learn More & Join Trial
BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis PHASE2 This is a randomized double blind, double dummy, placebo controlled, parall...
Show More Location
Multiple Locations
Learn More & Join Trial
BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis PHASE3 This is a randomized double blind, double dummy, placebo and active compara...
Show More Location
Multiple Locations
Learn More & Join Trial